Qingnuo Zeng

432 total citations
8 papers, 329 citations indexed

About

Qingnuo Zeng is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Qingnuo Zeng has authored 8 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Qingnuo Zeng's work include Pancreatic and Hepatic Oncology Research (2 papers), ATP Synthase and ATPases Research (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). Qingnuo Zeng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), ATP Synthase and ATPases Research (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). Qingnuo Zeng collaborates with scholars based in China and United States. Qingnuo Zeng's co-authors include Dongmin Chang, Wenhan Li, Bin Hou, Xin Xie, Yongchun Song, Hao Zhang, Zhangjian Zhou, Peng Xia, Ting Wang and Kun Guo and has published in prestigious journals such as Frontiers in Oncology, Frontiers in Genetics and Cellular Physiology and Biochemistry.

In The Last Decade

Qingnuo Zeng

8 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingnuo Zeng China	6	191	134	130	48	38	8	329
Yuanxi Huang China	9	180 0.9×	145 1.1×	149 1.1×	39 0.8×	32 0.8×	29	341
Jesús Gil‐Pulido Germany	7	116 0.6×	44 0.3×	117 0.9×	121 2.5×	23 0.6×	9	303
Estelle Carminita United States	6	77 0.4×	36 0.3×	83 0.6×	83 1.7×	14 0.4×	12	238
Chaozeng Si China	11	182 1.0×	76 0.6×	47 0.4×	46 1.0×	6 0.2×	30	281
Ping Qiang China	9	244 1.3×	110 0.8×	111 0.9×	45 0.9×	19 0.5×	30	352
Zhongxing Jiang China	13	164 0.9×	87 0.6×	118 0.9×	113 2.4×	36 0.9×	28	364
Yung‐Ming Cheng Taiwan	11	174 0.9×	79 0.6×	266 2.0×	28 0.6×	14 0.4×	13	452
Mingjie Zheng China	9	187 1.0×	167 1.2×	72 0.6×	38 0.8×	25 0.7×	17	306
Isabel Heidrich Germany	8	128 0.7×	192 1.4×	172 1.3×	24 0.5×	27 0.7×	18	321

Countries citing papers authored by Qingnuo Zeng

Since Specialization

Citations

This map shows the geographic impact of Qingnuo Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingnuo Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingnuo Zeng more than expected).

Fields of papers citing papers by Qingnuo Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingnuo Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingnuo Zeng. The network helps show where Qingnuo Zeng may publish in the future.

Co-authorship network of co-authors of Qingnuo Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingnuo Zeng. A scholar is included among the top collaborators of Qingnuo Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingnuo Zeng. Qingnuo Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Zeng, Qingnuo, et al.. (2024). Platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with gastric cancer undergoing radical resection. Frontiers in Oncology. 14. 1279011–1279011. 5 indexed citations

2.

Zeng, Qingnuo, et al.. (2023). Glucose metabolism‐based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma. The Journal of Gene Medicine. 26(1). e3620–e3620. 2 indexed citations

3.

Xu, Longwen, Shilong Wang, Qingnuo Zeng, et al.. (2023). Prognostic utility of TME-associated genes in pancreatic cancer. Frontiers in Genetics. 14. 1218774–1218774. 2 indexed citations

4.

Hou, Bin, Wenhan Li, Peng Xia, et al.. (2021). LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway. Cell Death Discovery. 7(1). 273–273. 39 indexed citations

5.

Hou, Bin, et al.. (2019). Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis. Disease Markers. 2019. 1–11. 96 indexed citations

6.

Hou, Bin, Wenhan Li, Jianhui Li, et al.. (2019). Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway. Oncology Reports. 43(2). 536–548. 34 indexed citations

7.

Li, Wenhan, Yongchun Song, Ming Ni, et al.. (2018). Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry. 45(4). 1663–1676. 49 indexed citations

8.

Li, Wenhan, Yongchun Song, Hao Zhang, et al.. (2017). Decreased Expression of Hsa_circ_00001649 in Gastric Cancer and Its Clinical Significance. Disease Markers. 2017. 1–6. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact